Case Challenge

Management of a Genotype 1 HCV Patient in a Methadone Maintenance Program

Source: Understanding and Implementing the AASLD’s 2009 Practice Guidelines* on the Diagnosis, Management, and Treatment of Hepatitis C: An Update

Management of a Genotype 1 HCV Patient in a Methadone Maintenance Program

Program Director: Bruce R. Bacon, MD

Faculty:

David R. Nelson, MD

CREDIT INFORMATION

Release Date: September 11, 2009

Expiration Date: September 10, 2010

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Registered Nurses: 0.7 Nursing contact hours

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Identify and individualize HCV therapy based on pretreatment factors predictive of response to HCV therapy
Assess the impact of viral kinetics and treatment duration on achieving a sustained virologic response
Recount management strategies for adverse events related to HCV therapy

Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.